Orion Oyj (BIT:1ORNBV)
Italy
· Delayed Price · Currency is EUR 60.60
0.00 (0.00%)
At close: Aug 11, 2025, 5:30 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sale of Goods | 1.14B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sale of Goods Growth | 12.53% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Royalty Income | 271.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Royalty Income Growth | 120.82% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Milestone Payments | 133.80M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Milestone Payments Growth | 285.47% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Animal Health | 128.20M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Animal Health Growth | 19.74% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Fermion | 72.30M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Fermion Growth | -12.83% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Translation Differences and Other Operations | 800.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Translation Differences and Other Operations Growth | -250.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Innovative Medicines | 525.20M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Innovative Medicines Growth | 127.05% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Branded Products | 287.50M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Branded Products Growth | 10.32% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Generics and Consumer Health | 528.40M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Generics and Consumer Health Growth | 4.55% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| Finland | 347.40M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Finland Growth | 6.26% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Scandinavia | 163.10M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Scandinavia Growth | 13.77% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Europe | 431.30M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Europe Growth | 24.99% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America | 368.70M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America Growth | 116.76% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Markets | 231.90M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Markets Growth | 27.63% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2011 - 2018 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2011 - 2018 |
| Human Pharmaceuticals (Hospital and Pharmacy Channel) Reported Market Share |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Reference Priced Prescription Drugs (Pharmacy Channel) Reported Market Share |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Self-Care Products (Pharmacy Channel) Reported Market Share |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Prescription Drugs (Pharmacy Channel) Reported Market Share |
Log In |
Log In |
Log In |
Log In | Upgrade
|